Core EM - Emergency Medicine Podcast

Episode 211: Granulomatosis with Polyangiitis
Granulomatosis with Polyangiitis (GPA) – Recognition and Management in the ED
Hosts:
Phoebe Draper, MD
Brian Gilberti, MD
- A vasculitis affecting small blood vessels causing inflammation and necrosis
- Affects upper respiratory tract (sinusitis, otitis media, saddle nose deformity), lungs (nodules, alveolar hemorrhage), and kidneys (rapidly progressive glomerulonephritis)
- Can lead to multi-organ failure, pulmonary hemorrhage, renal failure
- Chronic sinus symptoms
- Hemoptysis (especially bright red blood)
- New pulmonary complaints
- Renal dysfunction
- Constitutional symptoms (fatigue, weight loss, fever)
- CBC, CMP for anemia and AKI
- Urinalysis with microscopy (hematuria, RBC casts)
- Chest imaging (CXR or CT for nodules, cavitary lesions)
- ANCA testing (not immediately available but important diagnostically)
- Stable patients: Outpatient workup, urgent rheumatology consult, prednisone 1 mg/kg/day
- Unstable patients: High-dose IV steroids (methylprednisolone 1 g daily x3 days), consider plasma exchange, cyclophosphamide or rituximab initiation, ICU admission
- Goodpasture syndrome (anti-GBM antibodies)
- TB, fungal infections
- Lung malignancy
- Other vasculitides (EGPA, MPA, lupus)
- C-ANCA/PR3-ANCA positive in 80-90% of GPA cases
- P-ANCA/MPO-ANCA more common in MPA
- Don’t delay treatment while awaiting results if suspicion is high
- Without treatment: Fatal within a year (renal failure, respiratory complications)
- With treatment: 5-year survival ~75-90%, but ~50% relapse rate
- Long-term rheumatology follow-up is essential
- Always include vasculitis in the differential for unexplained respiratory, renal, or systemic symptoms.
- Recognize pulmonary-renal syndromes early.
- Initiate high-dose steroids immediately for unstable patients without waiting for ANCA results.
- GPA is rare but life-threatening – early recognition saves lives.
Read More